Houston, Texas — According to state and local development sources, Eagle Analytical plans to invest $9,000,000.00 to build out 62,000 square feet of new space in Houston. The company plans to occupy the new space at 11111 S. Wilcrest Dr. in Houston, on or about October 1, 2024. According to the company website Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.It is our commitment to provide your organization with the tools to operate and maintain compliance within a highly regulated environment. In support of this commitment, Eagle is now home to professionals spanning the science and pharmaceutical industry, including experts in chemistry, microbiology, engineering, CGMP, quality control, and quality assurance. Our state-of-the-art 35,000 square foot facility and laboratory features innovative technologies and more lab space so we can increase our efficiency and have faster turnaround times for our clients.

To learn more about Eagle Analytical, visit http://eagleanalytical.com/

Company Contact:
Ross Caputo, Chief Executive Officer
rcaputo@eagleanalytical.com
800-745-8916

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.